Skip to content

Low-Intensity Mindfulness and Cognitive Behavioral Therapy for Social Anxiety Disorder: Pilot Study

Shota Noda, Yumi Honda, Chika Komatsu, Yosuke Hasegawa, Asuka Hasegawa, Fusaka Minami, Kentaro Shirotsuki, Mutsuhiro Nakao, Hisanobu Kaiya

International Journal of Cognitive Therapy June 30, 2023 DOI: 10.1007/s41811-023-00173-1 (opens in new tab)

The journal has published a correction to this paper. Read the correction (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Uncontrolled pre-post intervention study with repeated measures Pilot study Peer reviewed
Sample size 23
Population Patients with social anxiety disorder
Intervention Mindfulness and cognitive behavioral therapy (M-CBT)
Duration Four sessions; assessments at pretreatment, before each session, post-treatment, and follow-up
Topics Anxiety Meditation
Citations 14
Key points A four-session mindfulness plus cognitive behavioral therapy program produced significant improvements in social anxiety symptoms and cost bias, with high effect sizes (social anxiety symptoms: d = 1.04–1.06; cost bias: d = 0.82–1.02), and also improved fear of negative evaluation, self-focused attention, trait mindfulness, depressive symptoms, and cognitive reappraisal. The authors suggest the program is effective, feasible, and acceptable for social anxiety disorder and may serve as a treatment module for those not responding to traditional cognitive behavioral therapy.

Abstract

Abstract A four-session program of mindfulness and cognitive behavioral therapy (M-CBT) is a low-intensity treatment module for individuals with high cost/probability bias and social anxiety symptoms. We tested its effectiveness with 23 patients with social anxiety disorder. The patients completed a set of questionnaires that evaluated social anxiety symptoms, cost/probability bias, fear of negative evaluation from others, self-focused attention, trait mindfulness, depressive symptoms, cognitive reappraisal, and suppression at pretreatment, the time before each session of treatment, post-treatment, and follow-up. Linear mixed-effects models showed that the M-CBT was effective for social anxiety symptoms, cost/probability bias, fear of negative evaluation from others, self-focused attention, trait mindfulness, depressive symptoms, and cognitive reappraisal. The M-CBT also produced significant pre-post-improvements in social anxiety symptoms and cost bias with high effect sizes (social anxiety symptoms: d = 1.04–1.06, cost bias: d = 0.82–1.02). These results suggest that M-CBT is effective for treating social anxiety symptoms and cost bias. This study demonstrates that M-CBT is feasible and acceptable for social anxiety disorder. It may comprise a treatment module for those who do not respond to traditional cognitive behavioral therapy. Trial registration number: University Hospital Medical Information Network (UMIN CTR) UMIN000043720, Registered 23 Mar 2021.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Citations in the library

Explore topics